Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000033

COO and SVP, R&D sold 15,128 shares at $4.45 ($67,312)

From the SEC's structured data for this filing

Trades in this filing

Johnston Lloyd P. · COO and SVP, R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-17 Sale : show line 1 in the form −15,128 $4.45 $67,312 87,477 D
Open-market sales · 15,128 sh · avg $4.45 · $67,312
Loading xslF345X03/wf-form4_161618956509768.xml…